Commerzbank, Barclays

Commerzbank: Barclays' Equal Weight Call Tests Whether a Lighter Capital Load Can Carry the Stock

Published on 11/04/2026 at 12:50 | Editorial boerse-global.de
ECB cut Commerzbank's 2027 Pillar 2 requirement to 2.10%, but Barclays downgraded the stock on deposit competition and weaker NII expectations.
Commerzbank, Barclays, Equal, Weight, Call, Tests, Whether, Lighter, Capital, Load Illustration mit AI erstellt.

Two narratives are running side by side on Commerzbank, and they answer different questions. One is about how much capital the bank must hold; the other is about how much money it can actually earn. A 5.5% share price jump has made that distinction more urgent than usual.

On the capital side, the picture has brightened. The ECB trimmed the bank's additional Pillar 2 own-funds requirement for 2027 by five basis points to 2.10%, a move confirmed roughly a week ago. According to Commerzbank, the pro-forma MDA threshold for hard core capital now sits at 10.26% of risk-weighted assets. A lower supervisory bar gives the lender more room to return cash to shareholders.

Barclays, though, is looking at the other half of the equation. On 22 October the broker cut its rating from "Overweight" to "Equal Weight" and trimmed its price target to EUR 41 from EUR 42, citing limited upside and tougher competition for deposits in Germany. Analyst Paola Sabbione now expects a weaker net interest income for the third quarter than she had previously modelled. The call was not a sell recommendation — it was a more guarded view of how much further the stock can run.

Deposits, Not Capital, Drive the Earnings Question

That downgrade shifts the yardstick. The prospect of a merger is one thing; the bank's ability to generate earnings on its own is another, and it is the latter that Barclays is questioning. A softer ECB buffer says nothing about whether the deposit war is easing, and a buyback programme says nothing about the net interest line.

The distinction matters because a reduced NII forecast is not the same as a year-on-year decline. It is a revision of the analyst's own expectations, not a reported result. The next hard data point arrives on 5 November, when Commerzbank is due to publish its third-quarter 2026 figures, according to media reports. Until then, Barclays' view remains a forecast.

Should investors sell immediately? Or is it worth buying Commerzbank?

Buybacks Are Already Happening — the Earnings Proof Is Not

Where capital return is concerned, the bank is past the stage of intentions. In a single reporting week Commerzbank repurchased 3,316,027 of its own shares, bringing the total bought back under the programme to 21,268,730. That is executed capital return, not a possibility sketched out in a presentation.

Set beside the ECB relief, the two developments form a more favourable picture than a mere statement of intent would. But they are not the same thing, and neither one substitutes for evidence on profitability. A lower regulatory requirement is not an announcement of extra distributions; a completed buyback does not prove that future payouts will rise. Supervisors set the capital bar, while the business has to generate the economic wherewithal to clear it.

UniCredit's Shadow Lingers

UniCredit remains a background factor. The Italian lender has indicated it would step up financing for German mid-sized companies in the event of a merger, a pledge Commerzbank welcomed. That commitment, however, is tied to a possible combination and is not a change that has already taken place.

What November 5 Has to Settle

The operative question for investors is whether the business figures can underpin the capital story. If they do, the distribution case gains real weight and the buyback can be read as part of an economically supported return of capital rather than a gesture. If they don't, the lower capital requirement remains an advantage — just a less sturdy foundation for a better valuation on its own.

There is a trap in conflating the two. Treating a softer capital buffer or a share count reduction as proof of rising profits mixes up separate measures. Should the quarterly numbers disappoint, the regulatory relief would likely fade in importance for the valuation, and the buyback would stand as a completed capital measure rather than a rebuttal of weaker operating trends.

Nor should the day's share price move be read too quickly as confirmation of any single explanation. Capital relief can support a positive reading of the stock without establishing a firm link to the session's gain. For anyone weighing the shares, the durability of the payout argument matters more than a tidy retrospective story for every price swing. The direction is clear enough: repetition of the buyback and capital headlines counts for little until the business figures give them something to stand on.

Ad

Commerzbank Stock: New Analysis - 4 November

Fresh Commerzbank information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Commerzbank analysis...

Disclaimer...
en | DE000CBK1001 | COMMERZBANK | boerse | 70456134 |